European COVID-19 diagnostics industry will see a considerable decline of 28.2% during the forecast period. Several projects for the development of COVID-19, diagnosis, and treatment were reported over the last few months in Europe. Additionally, on 22 July 2020, the European Commission declared nearly $117.8 million to co-fund a call for supporting R&D of coronavirus vaccines, and to develop diagnostic tests, treatments, and other prevention tools. This call was revealed by the Coalition for Epidemic Preparedness Innovations and will get the funding as part of the Commission pledge for the investment of nearly $1.2 billion from Horizon 2020 into the EU research and innovation programs.
Browse the full report description European COVID-19 Diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments, Reagents & Kits, and Laboratory Testing Services), by Technology Type (PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test), by Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, Saliva, and Others), and by End-Users (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes) and Forecast, 2020-2026 at https://www.omrglobal.com/industry-reports/europe-covid-19-diagnostics-market
As a part of this program, 18 new research projects that were short-listed for financing announced by the European Commission on 6th March 2020. These projects include improving epidemiology and public health, including preparedness and response to outbreaks, discovering new treatments, rapid point-of-care diagnostic tests, and the development of new vaccines. The rapid point-of-care testing funding is intended to improve efforts targeted to support front-line health workers to make the diagnosis more accurately and more quickly, which will decrease the risk of further spread of the COVID-19. Total EU funding for COVID-19 diagnostics was nearly $7.5 million, under 18 Horizon 2020 research projects on coronavirus (March 2020).
Market Coverage
|
Report Elements |
Details |
|
Study Period |
2020-2026 |
|
Segments Covered |
By Type |
|
Countries Covered |
By Type, By Technology Type, By Sample Type, and By End-User |
|
Key Companies Profiled |
BioMérieux SA, F.
Hoffmann-La Roche AG, Molecular Biology Systems, Altona Diagnostics GmbH, and
Edinburgh Genetics Ltd. |
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID-19
o Most affected region/segment
o Recommendations
European COVID-19 Diagnostics Market – Segmentation
By Type
By Technology Type
o Chromatographic Immunoassay
o Fluorescent Immunoassay
o Chemiluminescent Immunoassay
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Neutralization
o Chemiluminescent Immunoassay
By Sample Type
By End-Users
European COVID-19 Diagnostics Market – Segmentation by Geography
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/europe-covid-19-diagnostics-market